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An increased prevalence of dementia in people with a learning disability has been reported in the 
literature (Kerr, 2007: Dodd et al, 2015) with this being significantly increased in those with Down’s 
syndrome. In addition people with Down’s Syndrome are at an increased risk of developing 
dementia at an early age and are more likely to have serious adverse side effects from the leading 
pharmaceutical interventions such as Memantine (Hanney et al, 2012). Thus it is important to 
consider modifiable life style choices that reduce risk of dementia at an early stage in an individual’s 
life, changes later in life may still have some beneficial effect though this is likely to be less 
significant for the individual. One modifiable life style factor that has gained epidemiological support 
from a vast array of studies is dietary interventions.  Therefore the aim of this article is to review the 
evidence available on specific dietary interventions for people with a learning disability who may go 
on to develop a dementia. In order to support families, carers and professionals to use current 
evidence on nutrition that can improve the long term health of individuals with a learning disability.     
Prevalence studies in people with a learning disability have estimated that rates of dementia are 
around 13% in people aged over 50 and 22% in those over 65, with this rising up to 77% in those 
over 60 who have Down’s Syndrome (Kerr, 2007; Head et al, 2012). In comparison to 5-7% of those 
aged over 65 in the general population (Fiest et al, 2016; Prince et al, 2013). Head et al (2012) state 
that the degenerative process found in people with Down’s Syndrome starts early with indicators of 
intracellular beta-amyloid and increased reactive oxygen species and oxidative stress being detected 
around 16 years of age. This is clinically significant given that this neurological pattern typically leads 
to extracellular beta-amyloid plaques which contribute to the dementia pathology. Thus dietary 
interventions such as anti-oxidants, polyphenols and omega-3 fish oils that are anti-inflammatory 
and reduce oxidative stress are advocated for in the literature in addition to the homocysteine 
lowering B-vitamins (Rayman et al, 2015).  
Fish and Omega 3 polyunsaturated fatty acids.  
Individuals with a learning disability including Down’s Syndrome are low-frequency consumers of 
fish and omega-3 supplements and consume more pre-prepared meals which are higher in omega-6 
and saturated fatty acids. This has been reflected in reduced long chain omega-3 in erythrocyte cells 
of people with Down’s Syndrome (Nordstrom et al, 2015).   
Many large epidemiological studies indicate an association with fatty acid ratio’s and dementia while 
others fail to find such an association, as supported by the NIH state of the science Conference panel 
(2010) and Cochrane reviews who concluded that there is insufficient evidence to recommend 
omega 3 to prevent Alzheimer’s disease or dementia (Dacks et al, 2013). This divergence in results 
has been explained by the earlier findings of Morris et al (2003) who concluded that the omega-3 
fatty acid docosahexaenoic acid (DHA) but not eicosapentaenoic acids (EPA) found in fish oils 
positively correlated with Alzheimer’s disease. Therefore studies need to assess individual fatty acids 
present in blood samples rather than total fatty acid compositions. More recently Cunnane et al 
(2012) found that DHA did not significantly differ across 3 brain cortical regions of individuals with 
Alzheimer’s disease, mild cognitive impairment (MCI) or no cognitive impairment, while plasma DHA, 
n-6 fatty acids and oleic acid were lower in those with Alzheimer’s disease. They postulate that 
analyses of lower DHA will be missed if total lipids are analysed instead of individual plasma lipids. 
Therefore it is suggested that for those supporting individuals with a learning disability consideration 
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should be given on how to increase consumption of fatty fish that is high in DHA and use of olive oil 
for oleic acid.   
DHA and Arachadonic Acid are the most abundant fatty acids in the brain (making up 50% of brain 
fatty acids) which are incorporated into the cell membrane (Denis et al, 2013; Luchtman and Song, 
2013). The scientific explanation of fish oils comes from evidence that fish oils enable improved 
membrane fluidity, intracellular signalling, neurogenesis (the birth of new nerve cells) as well as 
preserve synaptic function /synaptogenesis. DHA and EPA are also believed to indirectly influence 
brain pathology through protection from inflammation which reduces amlyoid plaque aggregation, 
neuroprotectin D1 which protects against cellular oxidative damage in the brain (Corsinovi et al, 
2011), and through binding to peroxisome proliferator activated receptors (Dacks et al, 2013; 
Sydenham et al, 2012; Itua et al, 2010). In contrast omega 6 is pro-inflammatory increasing 
inflammatory mediators such as cyclo-oxygenases (Loef and Walach, 2013). Research has shown that 
these changes occur in the “frontal cortex, nucleus accumbens and the striatum, but also the 
hippocampus” (Luchtman and Song, 2013). Evidence has mainly come from animal studies for 
example decreased neurogenesis in the hippocampus of rats given omega 3 supplements and an 
increase in long term potentiation in glutamatergic synaptic efficacy in the hippocampus of rats that 
is associated with learning and memory. EPA has anti-oxidative properties that restored the 
electrophysiological properties of some neuronal circuits and memory in animal studies, while DHA 
enables protection of the glutaminegic synapse through enabling good gap junction coupling within 
astrocytes that maintain homeostasis (Denis et al, 2013). Criticism of mechanistic explanations come 
from researchers who argue that omega 3 indirectly effects cognitive functioning through improving 
cardiovascular and metabolic dysfunctions alongside vitamins (D,B and E found in fish) and 
antioxidants effecting brain atrophy on neuroimaging studies (Tan et al,2012). 
Denis et al (2013) argued that omega 3 polyunsaturated fatty acids (PUFA’s) slowed cognitive decline 
among older people without dementia from the general population and thus concurred that PUFA’s 
have a role in reducing risk of the onset of dementia.   However, fish oils may have reduced efficacy 
as a primary or secondary treatment for those already diagnosed with dementia. In vitro and animal 
models have found that DHA can change gene expression and reduce expression of inflammatory 
cytokines (de Urquiza et al, 2000; Vedin et al, 2012) which reduces risk of developing a dementia. 
Thus polyunsaturated fatty acids found in fish oils such as DHA are likely to be preventative rather 
than curative and thus ingestion of fatty fish at least once or twice a week should be encouraged 
early in life and this eating pattern maintained through to later life to delay onset of the 
neurodegenerative profile leading to dementia.  
Due to the interactive nature of nutrients in oily fish which provides an increased amount of 
vitamins (especially D, B, E and A), amino acids, selenium and other minerals (Lluis et al, 2013) the 
beneficial effects of consuming fish are above and beyond supplementation with fish or cod liver oil 
capsules.  In addition increasing evidence is pointing towards trans-fats and omega 3/6 ratios as 
being significant considerations as shown in the research by Loef and Walach (2013) and Milte et al 
(2011), thus advocating for replacing meals that are high in trans-fats such as burgers, take-aways 
and fried foods. The implications for practice is to promote a healthy diet including two servings a 
week of fatty fish such as salmon, mackerel or tuna when meal planning for service users with a 
learning disability.  
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B-vitamins. 
A deficiency in vitamin B12 effects up to 40% of sick or institutionalised people (Andres et al, 2004) 
which is known to lead to neurological disorders including cognitive impairment. This can be 
explained physiologically by high doses of homocysteine or deficits in B12 and B9 promoting amyloid 
and tau protein accumulation and neuronal apoptosis (Gillette-Guyonnet et al, 2013). Thus it has 
been recommended that people showing cognitive decline have serum cobalamin levels analysed 
(Health Quality Ontario, 2013). Therefore, diet as a modifiable risk factor provides an important 
avenue in which to reduce this bio-psychosocial burden in those with an existing learning disability.  
In the general population homocysteine has consistently been reported to correlate to Alzheimer’s 
disease in non-diabetic samples (Morris, 2012), with raised homocysteine concentrations increasing 
phosphorylated tau which causes neurofibrillary tangles which are a pre-requisite of Alzheimer’s like 
dementia (Coppede, 2010). B-vitamins have also been shown to reduce beta amyloid proteins which 
are believed to contribute to Alzheimer’s disease (Flicker et al, 2008) and their active forms are 
needed for DNA replication, histone methylation, neurogenesis, neural membrane formation and 
proliferation and erythrocyte synthesis (see de Jager et al, 2012 and Cacciapuoti, 2013 for reviews). 
Additional mechanisms proposed revolve around reducing oxidative stress, optimising utilization of 
omega 3 fatty acids (van Wijk et al, 2012) and reducing cardiovascular disease which is associated 
with hyperhomocysteinemia (Ham et al, 2014). 
 Results from epidemiological studies support the contention that B-vitamins reduce MCI and 
progression of the earlier stages of dementia including Alzheimer’s disease, potentially through 
lowering homocysteine. This relationship appears to be strongest for folate with efficacious results 
on various cognitive domains being reported (Morris, 2012). Further support comes from studies on 
brain atrophy using MRI brain scans with greatest impact of B-vitamins being shown by insufficiency 
in B12 and low holo-transcobalamin (Vogiatzoglou et al, 2008). Epidemiological studies are unable to 
show directional causality and evidence exists that age and neurocognitive decline effects 
malnutrition and consequently B-vitamin intake (von Arnim et al, 2013), thus causality may be bi-
directional. 
Randomised controlled trials have thus been warranted which have shown inconsistent results. 
Meta-analysis and sub-analysis of randomised controlled trials have highlighted that efficacy of 
treatment may be dependent on baseline characteristics including B-vitamins being within the sub-
optimal range and biomarkers such as homocysteine levels being above the threshold of 11.5µmol/L 
(Jerrneren et al, 2015; Smith et al, 2010). In addition combined treatment with folate B6 and B12 is 
more effective than single B-vitamins, with synergy with other nutrients such as poly-unsaturated 
fatty acids also increasing their efficacy (Jerrneren et al, 2015; Scheltens et al, 2012). Concurrently 
homocysteine levels decrease further with combined B-vitamin treatment compared to single 
preparations offering further support to this mechanistic theory (Vogel et al, 2009). 
B-vitamin trials have been  more effective in MCI and reducing speed of progression to dementia 
than in clinically diagnosed dementia cases, with 82% of known dementia cases being non-reversible 
(Djukic et al, 2015) and thus it is difficult to achieve either clinical or significant results in this cohort. 
More specific measures of dementia such as brain atrophy have shown some improvement following 
a course of B-vitamins particularly in posterior brain areas that are associated with dementia such as 
A HEALTHY DIET TO REDUCE THE RISK OF DEMENTIA IN 
PEOPLE WITH A LEARNING DISABILITY December 1, 2016 
 
the bilateral hippocampus, lingual and fusiform gyrus that are involved in visuo-spatial learning and 
memories with atrophy also noted in the cerebellum which is required for working and 
autobiographical memory (Douaud et al, 2013; Jerneren et al, 2015). This appears on further analysis 
to be related to vitamin B12 though further studies are required to corroborate this finding (Douaud 
et al, 2013). Thus B-vitamins may make subtle differences in those with MCI and those already 
diagnosed with dementia which are enhanced by duration of treatment.  It is therefore important to 
encourage children with a learning disability to eat dark green leafy vegetables, yeast extract, milk 
and foods high in B12 and folate which they can continue to consume through adulthood to older 
ages.  
Recently Prasher and Prasher (2016) have published their findings from a study on serum folate and 
B12 levels in individuals with Down’s Syndrome concluding that no significant association was found 
between these nutrients and Alzheimer’s disease.  Critique of these findings are based on the small 
sample size (66 adults with Down’s Syndrome and dementia compared to 37 individuals with Down’s 
Syndrome not diagnosed with Alzheimers Disease). The authors of this paper highlight this as a 
possible reason for the heterogeneity with studies conducted in the general population. Further 
criticism comes from the mean age of the sample and controls being 56 years, due to beta-amyloid 
plaques developing in their 30’s or earlier, it could be postulated that some participants in the 
control group had the early stages of dementia which the diagnostic criteria failed to recognise given 
the atypical presentation often found in people with Down’s Syndrome. 
Although none of the researchers from studies cited above have reported adverse effects from B-
vitamin supplementation caution should be taken when recommending B-vitamins without 
awareness of current nutrient status due to the finding of Moore et al (2014) and Malouf et al 
(2008). These researchers showed that B-vitamin supplementation may be detrimental to cognition 
in those that have optimal levels of B12 prior to supplementation. An additional warning comes from 
evidence that folic acid supplementation can mask B12 deficiency leading to neurological damage 
(Morris et al, 2007). A recent systematic analysis by Otaegui-Arrazola et al (2014) concluded that 
studies giving a low dose of B-vitamins are more likely to have positive results on cognitive decline 
than those giving supra-pharmacological doses. No adverse effects have been reported from 
encouraging individuals to consume foods that are high in the B-vitamins making this a viable option 
for individuals with a learning disability with unknown serum levels. The additional benefit of a 
healthy diet incorporating a range of B-vitamins comes from evidence that these nutrients work in 
synergy with omega-3 fatty acids and that a nutrient rich diet will also provide a range of vitamins, 
minerals, anti-oxidants and polyphenols that can work in conjunction to improve health outcomes.   
Anti-oxidants and polyphenols.  
Anti-oxidants such as vitamin C and vitamin E as well as minerals including selenium have been 
proposed as important for a brain protective diet to reduce risk of neuro-degeneration (Rayman et 
al, 2015). Plant food sources are also rich in other chemical compounds that limit damage caused by 
pathogens and radiation from sunlight (UVB) these substances that can be metabolised and used as 
anti-oxidants by the body are known as polyphenols.  Anti-oxidants and polyphenols can be found in 
a variety of food sources such as fruit, vegetables and nuts. These highly nutritious foods provide 
sources of polyphenols such as anthocyanins found in berries and red skinned fruits, hesperidin 
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found in citrus foods, tocopherols found in pistachio nuts, phenylethanoid found in olive oil and 
flavonols in dark chocolate.  
In the general population research into the mechanistic actions of polyphenols impact on the brain 
has been conducted. One polyphenol that has received a lot of interest is anthocyanins which are 
found in red fruit and berries. These have been found to reduce oxidative stress, inflammation and 
viral infections in addition to their anti-proliferative properties (Subash et al, 2014). Blueberries and 
strawberries have also been found to enhance dopamine and thus intracellular communication 
within the brain and reverse declines in β-adrenergic receptor function (Bickford et al, 2000; Balk et 
al, 2006), that inhibit the formation of and destabilise β-amyloid fibrils, reduce ratios of Aβ40/42, 
improve brain glutathione and ascorbate levels,  and inhibit COX 1 and 2 expression which are key 
pathogenic features due to increased Reactive Oxygen Species (ROS) in neurodegenerative diseases 
such as dementia (Vepsäläinen et al, 2013; Subash et al, 2014). 
Anthocyanin aglycons such as cyaniding-3-0-β-D-glucopyranoside have also been found to reduce 
cerebral ischemic damage through reduction of ROS, as shown by significantly reduced infarct 
volume and increased cell viability following oxygen glucose deprivation in vitro and in vivo (Kang et 
al, 2006; Sweeney et al, 2002). Finally evidence is also emerging that berries may provide benefit for 
multiple sclerosis patients (Xin et al, 2012). 
Studies on dietary intakes of people with a learning disability have reported an increase in snacking 
between meals as well as an increased consumption of bread, cakes, meat products and milk and 
reduced consumption of fruit and vegetables compared to the general population (Adolfsson et al 
2008). This is corroborated by recommended daily intakes and biochemical markers of micro-
nutrients not meeting the recommended amounts (Hoey et al 2016). Thus it could be postulated 
that people with a learning disability consume less antioxidants and polyphenols which has the 
potential to increase reactive oxygen species and pathological damage. 
Studies in people with Down’s Syndrome have only investigated 3 polyphenol compounds including 
Epigallocatechin-3-gallate found in green tea, resveratrol found in red grapes and Hydroxytyrosol 
from olive oil. These have all significantly reduced oxidative stress or regulated mitochondrial stress 
reducing impaired neurogenesis as well as suppressing neuroinflammation which are hallmarks of 
the neuro degenerative disorders (Vacca et al, 2016). Further studies are now needed to investigate 
the effects of other antioxidants such as anthocyanins, hesperidin, tocopherols and flavonols in 
people with Down’s Syndrome.  
Conclusion.  
A varied diet that is rich in fruit, vegetables, nuts, olive oil, milk and the occasional piece of dark 
chocolate can serve as protective of developing a dementia. With evidence that encouraging a 
healthy and varied diet early in life and sustaining this through adulthood and later in life promotes 
neurological health. The biopsychosocial benefits of reducing the double burden of developing 
degenerative diseases in people with a learning disability is an important consideration for any 
healthcare professional given the increased prevalence rates of dementia found in people with a 
learning disability. 
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Implications for practice.  
Encourage people with a learning disability to eat fatty fish such as salmon, mackerel or tuna twice a 
week.  
Encourage snacks of fruit or vegetables crudités. Citrus fruit, peppers, plums, grapes and berries are 
particularly good as they are high in antioxidants such as vitamin C as well as polyphenols.  
Ground or whole nuts such as pistachios and brazil nuts that are high in selenium can be added to 
breakfast cereal to increase antioxidant intake.  
Ensure that good sources of vitamin B12 and folate are provided, which can be found in dark green 
leafy vegetables, milk, yeast extract, unprocessed red meat.  
Multi-disciplinary team involvement from dieticians, General Practitioners and Learning Disability 
Nurses can offer valuable support and guidance in meeting nutrient requirements of individuals in 
accordance to their specific needs and preferences.  
General Practitioners can also organise for serum levels of B-vitamins and other nutrients  to be 
checked to ensure that deficiencies are not left untreated.  
Remember the earlier in life individuals with a learning disability start to eat healthy the better, but 
it’s never too late.   
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